The combined results of two independent groups of researchers represent major progress in the development of safer, more efficiently produced iPS (induced pluripotent stem) cells.
Sir Ian Wilmut and Dr. Shinya Yamanaka are among those honored at a glittering ceremony in Hong Kong for their pioneering work.
A controversial embryonic stem cell company in Massachusetts fights to survive as it struggles with increasing debt.
In a visually dramatic graphical representation, Drs. Rudolf Jaenisch and Christopher Lengner describe and contrast the properties of embryonic stem cells and pluripotent cells derived from non-embryonic sources.
NeoStem CEO, Dr. Robin Smith, will speak about “medical tourism” at the 2008 World Stem Cell Summit.
Scientists have transformed one type of adult cell into another type, without the use of stem cells.
Toll Free:
1-800-980-STEM (7836)
Outside or Inside US Call:
1-954-358-3382
Toll Free Fax (US Only):
1-866-755-3951
From Outside US Fax:
1-775-887-1194
Copyright 2025, Stem Cell Insitute Panama. All rights reserved.